Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline

(2011) Sujata M. Bhavnani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Interleukin-6 in Sepsis and Capillary Leakage Syndrome

(2011) Alexander Krüttgen et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

(2010) C. M. Rubino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!

(2010) Paul G. Ambrose et al.   CLINICAL INFECTIOUS DISEASES

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

(2010) Antonio T. Freire et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint

(2009) Olaf Burkhardt et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs

(2009) J. L. Crandon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

(2009) Cristina Tanaseanu et al.   BMC Pulmonary Medicine

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

(2008) Cristina Tanaseanu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

(2008) Carlos Bergallo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE